Develops novel therapies for pediatric genetic diseases
Minoryx Therapeutics has raised €74M across 4 funding rounds from 6 investors, most recently a Series C round in May 2022. Based in Mataró, Spain; founded 2011; active in Healthtech. Data as of 7 Aug 2026.
Timing: dormant vs cohort gap · momentum up. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage | Amount | Investors |
|---|
| 2022-05-31 | Series C | €51M | Caixa Capital Risc,Columbus Venture Partners,FundPlus,Ysios Capital | View deal → |
| 2015-10-01 | Series A | €19M | Caixa Capital Risc,IDInvest Partners,Ysios Capital | View deal → |
| 2015-01-01 | Early VC | €1.6M | Caixa Capital Risc | View deal → |
| 2013-04-01 | Series A | €1.5M | Caixa Capital Risc,Inveready | View deal → |
